logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
15/05/2025
Needham: Maintains a buy rating on Inozyme Pharma (INZY.US), adjusted from a buy rating to a buy rating, with a target price adjusted from $15.00 to $12.00.
Latest
3 m ago
Actively seize market opportunities, new funds boldly establish positions.
3 m ago
Favorable factors resonate to increase market attention, multiple consumer-targeted stocks are recommended for buy-in.
3 m ago
Shenzhens industrial chain advantages promote the acceleration of the development of intelligent transportation.
4 m ago
Numerous organizations conducted surveys on over 50 humanoid robot companies in the industry chain.
4 m ago
Apple plans to release a foldable screen phone in 2026, and companies in the supply chain are expected to benefit from it.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.